InsiderTrades.com logo
Stop Overtrading
From Vantage Point   |   Ad
If you want better trades and better trading information, join us, live in a free online class. 

We’ll show you how to stay the course and trade emotion-free.

This is a completely complimentary class.
Save your seat now!

ANVS Insider Trading (Annovis Bio)

Insider Ownership Percentage: 42.60%
Insider Buying (Last 12 Months): $520,791.46
Insider Selling (Last 12 Months): $0.00

Annovis Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Annovis Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Annovis Bio Share Price & Price History

Current Price: $9.42
Price Change: +0.30 (1.20%)
As of 05/16/2022 01:00 AM ET

This chart shows the closing price history over time for ANVS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
How You Should Be Choosing Your Stocks
From Vantage Point   |   Ad
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.

Annovis Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/11/2021Claudine BruckDirectorBuy181$27.66$5,006.46View SEC Filing Icon  
10/11/2021Maria-Luisa MaccecchiniCEOBuy18,000$27.61$496,980.00View SEC Filing Icon  
8/19/2021Reid McCarthyDirectorBuy500$37.61$18,805.006,829View SEC Filing Icon  
See Full Table
How the Pros Choose Their Stocks
From Vantage Point   |   Ad
Grab your seat at our free, LIVE, masterclass for traders.

It’s your chance to learn how to pick the right stocks and find the market bottom.

We’ll reveal 3 Tips for dodging volatility and a few under-the-radar stocks we believe have significant potential in the long run.
Click here now to register.

SEC Filings (Institutional Ownership Changes) for Annovis Bio (NYSE:ANVS)

13.68% of Annovis Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ANVS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Annovis Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2022Renaissance Technologies LLC23,197$0.31M0.0%+120.9%0.284%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.242,461$3.24M0.0%+5.8%2.971%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp25,525$0.34M0.0%-17.4%0.313%Search for SEC Filing on Google Icon
5/4/2022Advisor Group Holdings Inc.2,870$38K0.0%-66.6%0.035%Search for SEC Filing on Google Icon
5/3/2022Sterling Investment Advisors Ltd.18,974$0.25M0.1%+31.1%0.233%Search for SEC Filing on Google Icon
5/3/2022Modera Wealth Management LLC31,313$0.42M0.0%-3.1%0.384%Search for SEC Filing on Google Icon
4/20/2022Essex LLC11,593$0.16M0.0%+9.4%0.142%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.147,599$2.60M0.0%+42.8%1.822%Search for SEC Filing on Google Icon
2/19/2022Wells Fargo & Company MN8,777$0.16M0.0%-10.2%0.108%Search for SEC Filing on Google Icon
2/17/2022Goldman Sachs Group Inc.10,273$0.18M0.0%N/A0.127%Search for SEC Filing on Google Icon
2/15/2022Marshall Wace LLP1,679$29K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC67,144$1.18M0.0%+2.3%0.829%Search for SEC Filing on Google Icon
2/15/2022Cubist Systematic Strategies LLC11,743$0.21M0.0%N/A0.145%Search for SEC Filing on Google Icon
2/14/2022Citadel Advisors LLC59,147$1.04M0.0%+58.9%0.730%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.10,273$0.18M0.0%N/A0.127%Search for SEC Filing on Google Icon
2/11/2022Renaissance Technologies LLC10,500$0.19M0.0%N/A0.130%Search for SEC Filing on Google Icon
2/9/2022Cannell & Co.10,000$0.18M0.0%-38.3%0.123%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE12,151$0.21M0.0%-30.5%0.150%Search for SEC Filing on Google Icon
2/4/2022Modera Wealth Management LLC32,313$0.57M0.0%-3.0%0.399%Search for SEC Filing on Google Icon
2/3/2022Advisor Group Holdings Inc.8,594$0.15M0.0%-21.9%0.106%Search for SEC Filing on Google Icon
1/28/2022Essex LLC10,593$0.19M0.0%-11.4%0.131%Search for SEC Filing on Google Icon
11/18/2021Bank of New York Mellon Corp26,036$0.83M0.0%+17.4%0.321%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP30,200$0.96M0.0%+906.7%0.373%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP97,566$3.10M0.0%N/A1.204%Search for SEC Filing on Google Icon
11/16/2021Voloridge Investment Management LLC108,738$3.45M0.0%+6.2%1.342%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC65,619$2.08M0.0%+1,729.4%0.810%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC37,222$1.18M0.0%N/A0.459%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley37,966$1.21M0.0%+26.3%0.469%Search for SEC Filing on Google Icon
11/15/2021Wealthspire Advisors LLC7,500$0.24M0.0%+50.0%0.093%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC40,945$1.30M0.0%+6.2%0.505%Search for SEC Filing on Google Icon
11/12/2021AIGH Capital Management LLC66,469$2.11M0.4%-47.4%0.821%Search for SEC Filing on Google Icon
11/9/2021Sterling Investment Advisors Ltd.14,474$0.46M0.1%-29.6%0.179%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.103,330$3.28M0.0%+2.3%1.276%Search for SEC Filing on Google Icon
11/5/2021Advisor Group Holdings Inc.11,002$0.35M0.0%+531.6%0.136%Search for SEC Filing on Google Icon
11/4/2021Modera Wealth Management LLC33,298$1.06M0.1%-4.2%0.411%Search for SEC Filing on Google Icon
10/29/2021Wescott Financial Advisory Group LLC41,607$1.32M0.7%N/A0.514%Search for SEC Filing on Google Icon
10/21/2021Essex LLC11,962$0.38M0.1%N/A0.148%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC17,442$1.49M0.1%+119.4%0.215%Search for SEC Filing on Google Icon
9/3/2021Parametric Portfolio Associates LLC22,331$1.91M0.0%N/A0.276%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley30,070$2.57M0.0%N/A0.371%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC103,527$8.86M0.7%-46.5%1.278%Search for SEC Filing on Google Icon
8/17/2021Wells Fargo & Company MN537$47K0.0%+2,048.0%0.007%Search for SEC Filing on Google Icon
8/17/2021Worth Venture Partners LLC33,834$2.90M1.1%+12.9%0.418%Search for SEC Filing on Google Icon
8/17/2021Knoll Capital Management LLC39,210$3.36M1.8%N/A0.484%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC3,587$0.31M0.0%N/A0.044%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD3,000$0.26M0.0%N/A0.037%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC11,756$1.01M0.0%-46.5%0.145%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC23,600$2.02M0.0%+4.9%0.291%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC4,508$0.39M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley30,070$2.57M0.0%N/A0.371%Search for SEC Filing on Google Icon
8/16/2021Diametric Capital LP12,458$1.07M0.8%-26.0%0.154%Search for SEC Filing on Google Icon
8/16/2021State Street Corp17,300$1.48M0.0%N/A0.214%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.25,819$2.21M0.0%N/A0.319%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp9,098$0.78M0.0%+22.5%0.112%Search for SEC Filing on Google Icon
8/13/2021RKL Wealth Management LLC5,000$0.43M0.1%-50.0%0.062%Search for SEC Filing on Google Icon
8/13/2021Wealthspire Advisors LLC5,000$0.43M0.0%-50.0%0.062%Search for SEC Filing on Google Icon
8/13/2021LPL Financial LLC3,868$0.33M0.0%N/A0.048%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC38,569$3.30M0.0%+39.8%0.476%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.229,453$19.64M0.0%+56.1%2.832%Search for SEC Filing on Google Icon
8/13/2021EAM Global Investors LLC29,590$2.53M0.7%N/A0.365%Search for SEC Filing on Google Icon
8/13/2021EAM Investors LLC48,643$4.16M0.6%+9.0%0.600%Search for SEC Filing on Google Icon
8/12/2021AIGH Capital Management LLC126,469$10.82M1.9%+7.9%1.561%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.8,024$0.69M0.0%N/A0.099%Search for SEC Filing on Google Icon
8/12/2021L & S Advisors Inc19,530$1.67M0.2%N/A0.241%Search for SEC Filing on Google Icon
8/11/2021Commonwealth Equity Services LLC3,964$0.34M0.0%N/A0.049%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp22,168$1.90M0.0%N/A0.274%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.100,997$8.64M0.0%N/A1.247%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG4,367$0.37M0.0%N/A0.054%Search for SEC Filing on Google Icon
8/11/2021Redmond Asset Management LLC7,750$0.66M0.2%N/A0.096%Search for SEC Filing on Google Icon
8/10/2021Virtus ETF Advisers LLC2,518$0.22M0.1%N/A0.031%Search for SEC Filing on Google Icon
8/10/2021National Asset Management Inc.2,430$0.21M0.0%N/A0.030%Search for SEC Filing on Google Icon
8/9/2021Broderick Brian C4,000$0.34M0.1%N/A0.049%Search for SEC Filing on Google Icon
8/9/2021Cannell Peter B & Co. Inc.16,000$1.37M0.0%+60.0%0.198%Search for SEC Filing on Google Icon
8/6/2021Sei Investments Co.15,244$1.31M0.0%N/A0.188%Search for SEC Filing on Google Icon
8/5/2021US Bancorp DE500$43K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/3/2021Absher Wealth Management LLC6,329$0.54M0.1%N/A0.078%Search for SEC Filing on Google Icon
8/2/2021Advisor Group Holdings Inc.1,742$0.15M0.0%-58.5%0.022%Search for SEC Filing on Google Icon
8/2/2021Modera Wealth Management LLC34,746$2.97M0.2%-14.5%0.429%Search for SEC Filing on Google Icon
7/31/2021Sterling Investment Advisors Ltd.20,574$1.76M0.5%-35.1%0.254%Search for SEC Filing on Google Icon
6/10/2021Lokken Investment Group LLC17,411$0.49M0.4%-45.9%0.251%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC7,951$0.22M0.0%N/A0.114%Search for SEC Filing on Google Icon
5/19/2021Worth Venture Partners LLC29,968$0.84M0.4%-74.9%0.431%Search for SEC Filing on Google Icon
5/19/2021Diametric Capital LP16,837$0.47M0.4%N/A0.242%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC8,963$0.25M0.0%N/A0.129%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC193,368$5.40M0.2%N/A2.783%Search for SEC Filing on Google Icon
5/14/2021Brown Advisory Inc.7,442$0.21M0.0%-50.2%0.107%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC19,900$0.56M0.0%N/A0.286%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp7,425$0.21M0.0%N/A0.107%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC27,583$0.77M0.0%N/A0.397%Search for SEC Filing on Google Icon
5/11/2021EAM Investors LLC44,640$1.25M0.2%N/A0.643%Search for SEC Filing on Google Icon
5/10/2021RKL Wealth Management LLC10,000$0.28M0.0%N/A0.144%Search for SEC Filing on Google Icon
5/4/2021Sterling Investment Advisors Ltd.31,678$0.88M0.3%-37.4%0.456%Search for SEC Filing on Google Icon
4/23/2021BRYN MAWR TRUST Co14,643$0.41M0.0%N/A0.211%Search for SEC Filing on Google Icon
2/11/2021Modera Wealth Management LLC43,846$0.33M0.0%N/A0.635%Search for SEC Filing on Google Icon
2/8/2021Lokken Investment Group LLC32,211$0.24M0.2%N/A0.466%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Annovis Bio logo
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Read More on Annovis Bio

Today's Range

Now: $9.42
Low: $9.18
High: $10.35

50 Day Range

MA: $12.26
Low: $8.81
High: $14.55

52 Week Range

Now: $9.42
Low: $8.39
High: $132.00

Volume

25,768 shs

Average Volume

39,661 shs

Market Capitalization

$76.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.11

Who are the company insiders with the largest holdings of Annovis Bio?

Annovis Bio's top insider investors include:
  1. Reid Mccarthy (Director)
  2. Claudine Bruck (Director)
  3. Maria-Luisa Maccecchini (CEO)
Learn More about top insider investors at Annovis Bio.

Who are the major institutional investors of Annovis Bio?

Annovis Bio's top institutional shareholders include:
  1. Vanguard Group Inc. — 2.97%
  2. Modera Wealth Management LLC — 0.38%
  3. Bank of New York Mellon Corp — 0.31%
  4. Renaissance Technologies LLC — 0.28%
  5. Sterling Investment Advisors Ltd. — 0.23%
  6. Essex LLC — 0.14%
Learn More about top institutional investors of Annovis Bio stock.

Which institutional investors are selling Annovis Bio stock?

During the previous quarter, ANVS stock was sold by these institutional investors:
  1. Advisor Group Holdings Inc.
  2. Bank of New York Mellon Corp
  3. Modera Wealth Management LLC

Which institutional investors are buying Annovis Bio stock?

In the last quarter, ANVS stock was acquired by institutional investors including:
  1. Vanguard Group Inc.
  2. Renaissance Technologies LLC
  3. Sterling Investment Advisors Ltd.
  4. Essex LLC
Within the last year, these company insiders have bought Annovis Bio stock:
  1. Reid Mccarthy (Director)
  2. Claudine Bruck (Director)
  3. Maria-Luisa Maccecchini (CEO)
Learn More investors buying Annovis Bio stock.
Analysts Favor Stock Like This
From Wealthy Millionaire   |   Ad
This little-known stock shows signs of unprecedented potential under founder & discovery minded CEO.
Click here for the full details.